Search Results | American Association for Cancer Research

1-20 of 158

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Unlocking the Mysteries of Lobular Breast Cancer Biology Needs the Right Combination of Preclinical Models

Shaymaa Bahnassy, Matthew J. Sikora, Rebecca B. Riggins

Mol Cancer Res (2022) 20 (6): 837–840.

DOI: https://doi.org/10.1158/1541-7786.MCR-22-0018

Published: 03 June 2022

View article

Journal Articles

Enhancing the Trajectories of Cancer Health Disparities Research: Improving Clinical Applications of Diversity, Equity, Inclusion, and Accessibility

Rachel Martini, Endale Gebregzabher, Lisa Newman, Melissa B. Davis

Cancer Discov (2022) 12 (6): 1428–1434.

DOI: https://doi.org/10.1158/2159-8290.CD-22-0278

Published: 02 June 2022

View article

Journal Articles

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

Blood Cancer Discov OF1–OF12.

DOI: https://doi.org/10.1158/2643-3230.BCD-21-0205

Published: 02 June 2022

View article

Includes: Supplementary data

Journal Articles

Next-Generation CAR T-cell Therapies

Regina M. Young, Nils W. Engel, Ugur Uslu, Nils Wellhausen, Carl H. June

Cancer Discov OF1–OF14.

DOI: https://doi.org/10.1158/2159-8290.CD-21-1683

Published: 12 April 2022

View article

Journal Articles

Hallmarks of Resistance to Immune-Checkpoint Inhibitors

Cancer Immunol Res (2022) 10 (4): 372–383.

DOI: https://doi.org/10.1158/2326-6066.CIR-20-0586

Published: 01 April 2022

View article

Journal Articles

Building Tools for Machine Learning and Artificial Intelligence in Cancer Research: Best Practices and a Case Study with the PathML Toolkit for Computational Pathology

Jacob Rosenthal, Ryan Carelli, Mohamed Omar, David Brundage, Ella Halbert, Jackson Nyman, Surya N. Hari, Eliezer M. Van Allen, Luigi Marchionni, Renato Umeton, Massimo Loda

Mol Cancer Res (2022) 20 (2): 202–206.

DOI: https://doi.org/10.1158/1541-7786.MCR-21-0665

Published: 03 February 2022

View article

Includes: Supplementary data

Journal Articles

Pathology: Hub and Integrator of Modern, Multidisciplinary [Precision] Oncology

The AACR Pathology Task Force

Clin Cancer Res (2022) 28 (2): 265–270.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-1206

Published: 10 December 2021

View article

Journal Articles

Adaptive Evolution: How Bacteria and Cancer Cells Survive Stressful Conditions and Drug Treatment

Mariangela Russo, Alberto Sogari, Alberto Bardelli

Cancer Discov (2021) 11 (8): 1886–1895.

DOI: https://doi.org/10.1158/2159-8290.CD-20-1588

Published: 01 August 2021

View article

Journal Articles

Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic

Chris Labaki, Solange Peters, Toni K. Choueiri

Cancer Discov (2021) 11 (6): 1330–1335.

DOI: https://doi.org/10.1158/2159-8290.CD-21-0210

Published: 01 June 2021

View article

Journal Articles

A Parathyroid–Gut Axis: Hypercalcemia and the Pathogenesis of Gastrinoma in Multiple Endocrine Neoplasia 1

Wenzel M. Hackeng, Koen M.A. Dreijerink, G. Johan A. Offerhaus, Lodewijk A.A. Brosens

Mol Cancer Res (2021) 19 (6): 946–949.

DOI: https://doi.org/10.1158/1541-7786.MCR-21-0073

Published: 01 June 2021

View article

Journal Articles

Thinking Differently about Cancer Treatment Regimens

Jeff Settleman, João M. Fernandes Neto, René Bernards

Cancer Discov (2021) 11 (5): 1016–1023.

DOI: https://doi.org/10.1158/2159-8290.CD-20-1187

Published: 01 May 2021

View article

Journal Articles

Old Dog, New Trick: Type I IFN–Based Treatment for Acute Myeloid Leukemia

Abdullah Alsufyani, Rehab Alanazi, John F. Woolley, Lekh N. Dahal

Mol Cancer Res (2021) 19 (5): 753–756.

DOI: https://doi.org/10.1158/1541-7786.MCR-20-0871

Published: 01 May 2021

View article

Journal Articles

Emerging Trends in Cancer Drug Discovery—From Drugging the “Undruggable” to Overcoming Resistance

Joachim Rudolph, Jeff Settleman, Shiva Malek

Cancer Discov (2021) 11 (4): 815–821.

DOI: https://doi.org/10.1158/2159-8290.CD-21-0260

Published: 01 April 2021

View article

Journal Articles

At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer

Marina Chiara Garassino, Antoni Ribas

Cancer Immunol Res (2021) 9 (3): 261–264.

DOI: https://doi.org/10.1158/2326-6066.CIR-21-0008

Published: 01 March 2021

View article

Journal Articles

How Drosophila Can Inform the Emerging Paradigm of the Role of Antioxidants in Cancer

Leslie J. Saucedo, Rosalie E. Triolo, Kate E. Segar

Mol Cancer Res (2021) 19 (1): 38–41.

DOI: https://doi.org/10.1158/1541-7786.MCR-20-0172

Published: 04 January 2021

View article

Journal Articles

Lung-Enriched Mutations in the p53 Tumor Suppressor: A Paradigm for Tissue-Specific Gain of Oncogenic Function

Julie A. Barta, Steven B. McMahon

Mol Cancer Res (2019) 17 (1): 3–9.

DOI: https://doi.org/10.1158/1541-7786.MCR-18-0357

Published: 02 January 2019

View article

Journal Articles

Beyond the Cell Cycle: Enhancing the Immune Surveillance of Tumors Via CDK4/6 Inhibition

Andrea C. Chaikovsky, Julien Sage

Mol Cancer Res (2018) 16 (10): 1454–1457.

DOI: https://doi.org/10.1158/1541-7786.MCR-18-0201

Published: 02 October 2018

View article

Journal Articles

Specific Targeting of Oncogenes Using CRISPR Technology

Felix Oppel, Matthias Schürmann, Peter Goon, Andreas E. Albers, Holger Sudhoff

Cancer Res (2018) 78 (19): 5506–5512.

DOI: https://doi.org/10.1158/0008-5472.CAN-18-0571

Published: 01 October 2018

View article

Journal Articles

Cancer as a Social Dysfunction—Why Cancer Research Needs New Thinking

Robert Axelrod, Kenneth J. Pienta

Mol Cancer Res (2018) 16 (9): 1346–1347.

DOI: https://doi.org/10.1158/1541-7786.MCR-18-0013

Published: 04 September 2018

View article

Journal Articles

Does Racial Bias Affect NCI-Funded PIs' Willingness to Mentor Prospective Graduate Students?

Jeffrey D. Robinson, Nathan Dieckmann, Elizabeth Withers, Dena Hassouneh, Charles R. Thomas, Jr

Cancer Res (2018) 78 (17): 4809–4811.

DOI: https://doi.org/10.1158/0008-5472.CAN-18-0269

Published: 04 September 2018

View article

2 3 4 5

NARROW

Unlocking the Mysteries of Lobular Breast Cancer Biology Needs the Right Combination of Preclinical Models

Enhancing the Trajectories of Cancer Health Disparities Research: Improving Clinical Applications of Diversity, Equity, Inclusion, and Accessibility

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

Next-Generation CAR T-cell Therapies

Hallmarks of Resistance to Immune-Checkpoint Inhibitors

Building Tools for Machine Learning and Artificial Intelligence in Cancer Research: Best Practices and a Case Study with the PathML Toolkit for Computational Pathology

Pathology: Hub and Integrator of Modern, Multidisciplinary [Precision] Oncology

Adaptive Evolution: How Bacteria and Cancer Cells Survive Stressful Conditions and Drug Treatment

Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic

A Parathyroid–Gut Axis: Hypercalcemia and the Pathogenesis of Gastrinoma in Multiple Endocrine Neoplasia 1

Thinking Differently about Cancer Treatment Regimens

Old Dog, New Trick: Type I IFN–Based Treatment for Acute Myeloid Leukemia

Emerging Trends in Cancer Drug Discovery—From Drugging the “Undruggable” to Overcoming Resistance

At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer

How Drosophila Can Inform the Emerging Paradigm of the Role of Antioxidants in Cancer

Lung-Enriched Mutations in the p53 Tumor Suppressor: A Paradigm for Tissue-Specific Gain of Oncogenic Function

Beyond the Cell Cycle: Enhancing the Immune Surveillance of Tumors Via CDK4/6 Inhibition

Specific Targeting of Oncogenes Using CRISPR Technology

Cancer as a Social Dysfunction—Why Cancer Research Needs New Thinking

Does Racial Bias Affect NCI-Funded PIs' Willingness to Mentor Prospective Graduate Students?

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only